SCHEMBL8685246

SCHEMBL8685246

O=C1NC(=O)/C(=C/c2cccc3c2ccn3Cc2ccccc2-c2ccccc2)S1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 9/20 0.57
TTR P02766 2/20 0.49
MEN1 O00255 1/20 0.49
AKR1B1 P15121 1/20 0.49
KMT2A Q03164 1/20 0.49
PIM1 P11309 4/20 0.48
PIM3 Q86V86 4/20 0.48
PIM2 Q9P1W9 4/20 0.48
STK17B O94768 2/20 0.48
BCL2 P10415 2/20 0.48
CSNK2A2 P19784 2/20 0.48
CDK7 P50613 2/20 0.48
DAPK1 P53355 2/20 0.48
CAMK4 Q16566 2/20 0.48
MAPK15 Q8TD08 2/20 0.48
PNPLA2 Q96AD5 2/20 0.48
HIPK3 Q9H422 2/20 0.48
NAT1 P18440 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8813612 1.00 PARP1 (0.57) PARP1TTRMEN1AKR1B1KMT2A
SCHEMBL8813618 0.88 PARP1 (0.43) PARP1TTRMEN1AKR1B1KMT2A
SCHEMBL8690423 0.86 PARP1 (0.59) PARP1TTRMEN1AKR1B1KMT2A
SCHEMBL8813508 0.86 PARP1 (0.59) PARP1TTRMEN1AKR1B1KMT2A
SCHEMBL8690901 0.86 PARP1 (0.59) PARP1TTRMEN1AKR1B1KMT2A
SCHEMBL8809818 0.86 PARP1 (0.59) PARP1TTRMEN1AKR1B1KMT2A
SCHEMBL8685962 0.85 PARP1 (0.66) PARP1TTRMEN1AKR1B1KMT2A
SCHEMBL8685959 0.85 PARP1 (0.66) PARP1TTRMEN1AKR1B1KMT2A
SCHEMBL8810443 0.83 PARP1 (0.56) PARP1TTRMEN1AKR1B1KMT2A
SCHEMBL8685487 0.83 PARP1 (0.56) PARP1TTRMEN1AKR1B1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811439-A ANTIDIABETIC AGENTS; SIDE EFFECT REDUCTION; ANTILEPEMIC AGENTS SENGA PHARMACEUTICAL LABORATORY INC. (JP) 1998-09-22 US disclosed
EP-0780389-A1 Thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing them TOBISHI PHARMACEUTICAL CO., LTD. (JP) 1997-06-25 EP disclosed